EUVIMEDEUVIMED entdecken
Crossref

FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1

Hua Zeng, Junmei Xu, Rui Wu, Xin Wang, Yaqing Jiang, Qing Wang, Jiali Guo, Feng Xiao

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2024

DOI: 10.1016/j.bbadis.2024.167307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024. Verfasst von Hua Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Hauptthemen laut MEDLINE: Ferroptosis, Sepsis, Cardiomyopathies, Alpha-Ketoglutarate-Dependent Dioxygenase FTO. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a global health challenge that results in systemic inflammation, oxidative stress, and multi-organ dysfunction, with the heart being particularly susceptible. This study aimed to elucidate the effect of FTO, a key regulator in m6A methylation in septic cardiomyopathy, and its potential therapeutic implications. Cellular and animal models of septic myocardial injury were established. Moreover, it was revealed that ferroptosis, which is a form of programmed necrosis occurring with iron dependence, was activated within cardiomyocytes during septic conditions. The overexpression of FTO-suppressed ferroptosis alleviated heart inflammation and dysfunction and improved survival rates in vivo. However, the protective effects of FTO were attenuated by the overexpression of BACH1, which is a molecule negatively correlated with FTO. Mechanistically, FTO modulated the m6A modification of BACH1, suggesting a complex interplay in the regulation of cardiomyocyte damage and sepsis. Our findings reveal the potential of targeting the FTO/BACH1 axis and ferroptosis inhibitors as therapeutic strategies for sepsis-induced cardiac injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisSepsisCardiomyopathiesAlpha-Ketoglutarate-Dependent Dioxygenase FTOBasic-Leucine Zipper Transcription FactorsAnimalsMiceMaleMyocytes, CardiacMice, Inbred C57BLHumansAdenosineDisease Models, Animal

Stichwörter der Autor:innen

BACH1FTOFerroptosisSeptic cardiomyopathym(6)A methylation

Substanzen

Alpha-Ketoglutarate-Dependent Dioxygenase FTOBasic-Leucine Zipper Transcription FactorsFTO protein, mouseBach1 protein, mouseN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
  • Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Electronic address: xiaofengcsu@csu.edu.cn.

Zitieren

APA

Zeng, H., Xu, J., Wu, R., Wang, X., Jiang, Y., Wang, Q., Guo, J., & Xiao, F. (2024). FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2024.167307

Vancouver

Zeng H, Xu J, Wu R, Wang X, Jiang Y, Wang Q, et al. FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2024. doi:10.1016/j.bbadis.2024.167307

BibTeX
@article{Zeng2024,
  author = {Zeng, Hua and Xu, Junmei and Wu, Rui and Wang, Xin and Jiang, Yaqing and Wang, Qing and Guo, Jiali and Xiao, Feng},
  title = {FTO alleviated ferroptosis in septic cardiomyopathy via mediating the m6A modification of BACH1},
  journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
  year = {2024},
  doi = {10.1016/j.bbadis.2024.167307}
}
Kostenlos starten →